Thursday, March 06, 2025 | 02:56 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Divi's Labs surges 21% as USFDA to lift import alert for Visakhapatnam unit

The stock surged 21% to Rs 1,117 on the BSE in early morning trade on back of nearly four-fold jump in trading volumes.

Divi's Laboratories plant
Premium

Divi's Laboratories plant

SI Reporter Mumbai
Divi’s Laboratories surged 21% to Rs 1,117 on the BSE in early morning trade after the company announced that the US drug regulator will lift import alert for its Visakhapatnam unit.

“The company has been informed by the U.S. Food and Drug Administration (US-FDA) that it will be lifting the Import Alert 66-40 and moving to close out the Warning letter issued to the company's Unit-II at Visakhapatnam,” Divi’s Laboratories said in a regulatory filing.

On September 20, 2017, the company said that all the previous observations by USFDA regarding Unit-2 of its Visakhapatnam facility have been confirmed

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in